Related Experiment Video
Updated: Jan 10, 2026

10:29
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
2.1K
Adhirons are efficient tools to guide antiviral ligand discovery
Alex J Flynn1,2,3, Alex Derry2,4, Oliver Debski-Antoniak2,5,6
1School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, UK.
Communications Biology
|November 26, 2025
Summary
Researchers developed a new method using Adhirons, antibody-like proteins, to discover small molecule drugs that mimic their effects. This approach successfully identified potential inhibitors for viruses like Crimean-Congo Haemorrhagic Fever Virus and Influenza A Virus.
Area of Science:
- Biochemistry
- Drug Discovery
- Virology
Background:
- Adhirons are bacterial antibody-like proteins with high target affinity, useful in research.
- Therapeutic applications of Adhirons are limited, driving the need for alternative strategies.
- Small molecules mimicking Adhiron function are of significant interest for therapeutic development.
Purpose of the Study:
- To develop a novel pipeline for small molecule discovery using Adhirons as templates.
- To accelerate the identification of viral inhibitors through a ligand-based virtual screening workflow.
- To demonstrate the proof of concept using Adhirons against Crimean-Congo Haemorrhagic Fever Virus and Influenza A Virus.
Main Methods:
- Utilized Adhirons as starting templates in a ligand-based virtual screening workflow.
- Employed biophysical and cell-based assays to validate identified small molecule mimics.
- Combined Adhiron data with commercial libraries and structural approaches for inhibitor discovery.
Main Results:
- Successfully identified small molecule mimics with potential inhibitory activity against target viruses.
- Demonstrated the efficacy of the developed pipeline in identifying hits for viral systems.
- Validated the use of Adhirons in accelerating small molecule inhibitor discovery.
Conclusions:
- The developed pipeline effectively uses Adhirons to accelerate small molecule inhibitor discovery for viruses.
- Combining Adhirons, commercial libraries, and structural methods is a viable strategy for drug development.
- This approach holds promise for identifying novel therapeutics against viral infections.
Related Concept Videos
Ligand Binding Sites
14.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.8K
Ligand Binding Sites
8.5K
8.5K

